Ono Pharmaceutical Co. Ltd.
OPHLY | OTC
$5.29
+$0.14 (+2.72%)
Sep 22, 2026, 1:00 PM ET · Market open
Fiscal Quarter Period Ending | Q1 2027 Jun 29, 2026 | Q4 2026 Mar 30, 2026 | Q3 2026 Dec 30, 2025 | Q2 2026 Sep 29, 2025 | Q1 2026 Jun 29, 2025 | Q4 2025 Mar 30, 2025 | Q3 2025 Dec 30, 2024 | Q2 2025 Sep 29, 2024 | Q1 2025 Jun 29, 2024 | Q4 2024 Mar 30, 2024 | Q3 2024 Dec 30, 2023 | Q2 2024 Sep 29, 2023 | Q1 2024 Jun 29, 2023 | Q4 2023 Mar 30, 2023 | Q3 2023 Dec 30, 2022 | Q2 2023 Sep 29, 2022 | Q1 2023 Jun 29, 2022 | Q4 2022 Mar 30, 2022 | Q3 2022 Dec 30, 2021 | Q2 2022 Sep 29, 2021 | Q1 2022 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 24.47B | 833.03M | 29.38B | 22.89B | 17.67B | -6.55B | 14.95B | 16.85B | 24.79B | 17.43B | 48B | 56.92B | 42.38B | 19.15B | 43.36B | 41.98B | 39.04B | 20.68B | 25.12B | 28.43B | 30.8B |
Depreciation & Amortization | 9.1B | 9.78B | 9.77B | 9.48B | 9.24B | 8.73B | 9.17B | 4.62B | 4.38B | 4.71B | 4.34B | 4.56B | 4.53B | 4.5B | 4.32B | 4.33B | 4.3B | 4.64B | 4.4B | 4.4B | 4.29B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -3.19B | 13.14B | 5.19B | 4.3B | 5.27B | -38.47M | 32.04M | -4.09B | 7.66B | 459M | 841M | -1.69B | -2.76B | 5.61B | 94M | 63M | 36M | 8.76B | -14.77B | 14M | -14.22B |
Other Non-Cash Items | -23.58B | 1.95B | -3.67B | 7.56B | 700.49M | 36.56B | -24.08B | -28.75B | -22.22B | 7.85B | -21.67B | 1.59B | -31.79B | -5.07B | -2.62B | -1.55B | 6.43B | 439M | -14.84B | -2.56B | -13.85B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.92B | 38.24B | -2.44B | 12.99B | -24.24B | 255.91M | 24.46M | 7.51B | -6.95B | 19.17B | -5.9B | -16.7B | -24.76B | 25.97B | -10.98B | 3.15B | -16.7B | 8.68B | -27.65B | 3.35B | -14.49B |
Operating Cash Flow | 1.07B | 50.81B | 33.04B | 52.92B | 3.37B | 39B | 63.05M | 218.27M | 5.22M | 49.16B | 24.78B | 46.36B | -9.64B | 44.55B | 34.09B | 47.9B | 33.08B | 34.43B | -12.97B | 33.61B | 6.76B |
Capital Expenditures | -2.02B | -1.01B | -1.03B | -1.71B | -2.25B | -1.42B | -8.38M | -1.26B | -1.54B | -10.54B | -1.4B | -1.15B | -7.74B | -4.45B | -4.64B | -1.63B | -3.77B | -2.06B | -1.59B | -2.34B | -6.3B |
Cash Acquisitions | 8.11M | 11.37M | 3.06M | 7.24M | n/a | 18.67M | -57.04M | -5.9M | -364.82B | 34M | -615M | -311M | -5.23B | -3.05B | -3.97B | -530M | -1.61B | -474M | -705M | -488M | -5.1B |
Purchase of Investments | -844.98M | -1.89B | -1.2B | -1.31B | -1.18M | -7.11M | -9.91M | -4.63M | -779M | -790M | -3.57B | -31.19B | -1.19B | -86B | -3.35B | -51.16B | -88M | -50.5B | -886M | -7.18B | -50M |
Sales Maturities Of Investments | 1.76B | 7.33B | 741.33M | 4.94B | 39.9M | 105.83M | 113.57M | 46.65M | 1.31B | 40.19B | 2.55B | 62.96B | 315M | 35.68B | 1.01B | 16.29B | 2.88B | 41.06B | 25.92B | 9.86B | 1.75B |
Other Investing Acitivies | 8.25B | 190.43M | -52.46M | -343.24M | -40.72B | 16.75B | 1.24B | 1.29B | 366.08B | -196M | 1.69B | -411M | 4.65B | 2.41B | 4.02B | 419M | 1.27B | -44M | -710M | -1.09B | 4.57B |
Investing Cash Flow | 3.47B | 5.55B | -1.58B | 1.46B | -42.97B | 15.33B | 32.99M | 24.32M | -1.06B | 28.7B | -1.34B | 29.9B | -9.19B | -55.41B | -6.93B | -36.61B | -1.32B | -12.02B | 23.44B | -264M | -5.12B |
Debt Repayment | -3.6B | -3.43B | -5.94B | -7.72B | -8.35B | -8.31B | -26M | 2.85M | -697M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | 25.6K | 18.91K | -1M | n/a | 51.09 | -156 | -1M | n/a | -12.76B | -10.06B | -27.19B | n/a | n/a | n/a | n/a | -1M | -14.55B | -15.46B | n/a | n/a |
Dividend Paid | -17.7B | -230.82M | -18.41B | -1.34B | -17.4B | -992M | -17.77B | -1.32B | -17.44B | -1.03B | -18.1B | -1.22B | -16.83B | -942M | -15.15B | -998M | -12.65B | -805M | -13.15B | -1.06B | -12.65B |
Other Financial Acitivies | -841.94M | -790.87M | -864.6M | -859M | 37.03M | -51.09 | 17.64B | 1.3B | 18.98B | -700M | -544M | -702M | -709M | -670M | -657M | -712M | -702M | -649M | -654M | -635M | -626M |
Financial Cash Flow | -22.14B | -4.45B | -25.22B | -9.92B | -25.71B | -9.3B | -151.73M | -11.45M | 846.16M | -14.49B | -28.71B | -29.11B | -17.54B | -1.61B | -15.81B | -1.71B | -13.36B | -16B | -29.27B | -1.69B | -13.28B |
Net Cash Flow | -22.47B | 46.04B | -4.85B | 40.59B | -405.73M | 43.59B | -143.82M | 333.57M | -263.2M | 63.89B | -5.46B | 47.27B | -35.7B | -12.46B | 10.84B | 9.81B | 18.83B | 6.64B | -18.64B | 31.66B | -11.58B |
Free Cash Flow | -948.33M | 49.8B | 32.02B | 51.21B | 1.12B | 37.58B | 54.67M | 32.65B | -731M | 38.63B | 23.38B | 45.21B | -17.38B | 40.1B | 29.45B | 46.27B | 29.3B | 32.37B | -14.56B | 31.28B | 461M |
Adj. Free Cash Flow | -948.33M | 49.8B | 32.02B | 51.21B | 1.12B | 37.58B | 54.67M | 32.65B | -731M | 38.63B | 23.38B | 45.21B | -17.38B | 40.1B | 29.45B | 46.27B | 29.3B | 32.37B | -14.56B | 31.28B | 461M |
Maintenance CapEx | -2.02B | n/a | n/a | n/a | n/a | -1.42B | n/a | -1.26B | -1.54B | -9.12B | n/a | n/a | -3.66B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.7B |
Growth CapEx | n/a | -1.01B | -1.03B | -1.71B | -2.25B | n/a | -8.38M | n/a | n/a | -1.41B | -1.4B | -1.15B | -4.09B | -4.45B | -4.64B | -1.63B | -3.77B | -2.06B | -1.59B | -2.34B | -4.59B |
Owner Earnings | -948.33M | 50.81B | 33.04B | 52.92B | 3.37B | 37.58B | 63.05M | 32.65B | -731M | 40.04B | 24.78B | 46.36B | -13.29B | 44.55B | 34.09B | 47.9B | 33.08B | 34.43B | -12.97B | 33.61B | 5.05B |
Add to Watchlist
Select watchlists to add or remove OPHLY